- Tobramycin 300mg/4ml nebuliser liquid ampoules
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Tobramycin 300mg/4ml nebuliser liquid ampoules | Start Date 01-02-2010 | End Date |
Previous Name | Previous Name Tobramycin 75mg/ml nebuliser liquid 4ml ampoules | Start Date 05-01-2009 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 4
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Nebuliser liquid
- Ontology Form/Route
- solutionnebuliser.inhalation
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J01GB01
BNF | Start Date | End Date |
---|---|---|
Current BNF 05010400 | Start Date 04-04-2022 | End Date |
Previous BNF 05010400 | Start Date 05-11-2009 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
14801411000001105 | 05-01-2009 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Tobramycin | Based on Ingredient Substance | 75 mg | 1 ml |
Name
Tobramycin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
75
Strength and UOM (Dmr)
1
Parent Products
-
VTMTobramycin
-
VMP(Current) Tobramycin 300mg/4ml nebuliser liqui...
-
AMP
No AMPs
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
56 ampoule | 118700 | Part VIIIA Category C |